Abstract
Tumor angiogenesis represents efficient mechanism that allows survival of tumor cells and promotes tumor growth. Antiangiogenic strategies are widely tested in various tumor types.
The initial therapeutic attempts were focused on the inhibition of vascular epithelial growth factor signalling cascade and now research continues on other angiogenic signalling pathways (Tie, FGF).